Infection and immunity1996; 64(11); 4520-4524; doi: 10.1128/iai.64.11.4520-4524.1996

Antibacterial activity of antileukoprotease.

Abstract: Antileukoprotease (ALP), or secretory leukocyte proteinase inhibitor, is an endogenous inhibitor of serine proteinases that is present in various external secretions. ALP, one of the major inhibitors of serine proteinases present in the human lung, is a potent reversible inhibitor of elastase and, to a lesser extent, of cathepsin G. In equine neutrophils, an antimicrobial polypeptide that has some of the characteristics of ALP has been identified (M. A. Couto, S. S. L. Harwig, J. S. Cullor, J. P. Hughes, and R. I. Lehrer, Infect. Immun. 60:5042-5047, 1992). This report, together with the cationic nature of ALP, led us to investigate the antimicrobial activity of ALP. ALP was shown to display marked in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus. On a molar basis, the activity of ALP was lower than that of two other cationic antimicrobial polypeptides, lysozyme and defensin. ALP comprises two homologous domains: its proteinase-inhibitory activities are known to be located in the second COOH-terminal domain, and the function of its first NH2-terminal domain is largely unknown. Incubation of intact ALP or its isolated first domain with E. coli or S. aureus resulted in killing of these bacteria, whereas its second domain displayed very little antibacterial activity. Together these data suggest a putative antimicrobial role for the first domain of ALP and indicate that its antimicrobial activity may equip ALP to contribute to host defense against infection.
Publication Date: 1996-11-01 PubMed ID: 8890201PubMed Central: PMC174407DOI: 10.1128/iai.64.11.4520-4524.1996Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the antibacterial activity of Antileukoprotease (ALP), a protein found in the human lung, against two types of bacteria, Escherichia coli and Staphylococcus aureus. It suggests that one particular section of the ALP molecule may be responsible for this antimicrobial action and could contribute to the body’s defense against infection.

Introduction to Antileukoprotease (ALP)

  • Antileukoprotease (ALP), also known as secretory leukocyte proteinase inhibitor, is a naturally occurring inhibitor of serine proteinases.
  • It is found in various secretions and is a major inhibitor of serine proteinases in the human lung.
  • The ALP molecule is known to be a potent reversible inhibitor of an enzyme called elastase and less strongly of another enzyme known as cathepsin G.

ALP and Its Antimicrobial Property

  • fPrevious research identified an antimicrobial polypeptide in horse neutrophils with similarities to ALP.
  • Due to this and the ALP molecule’s cationic nature, which means it carries a positive charge, researchers speculated that ALP may have antimicrobial activity.
  • The studies confirmed that ALP indeed has significant in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus, two common types of bacteria.
  • However, when its antibacterial activity was compared on a molar basis, it was found to be less than that of two other positively charged antimicrobial polypeptides, lysozyme and defensin.

Identification of Antimicrobial Role of ALP’s First Domain

  • The ALP molecule is comprised of two homologous domains. The proteinase-inhibitory activities of ALP are located in its second domain, while the function of the first domain was not well-established.
  • Experiments were conducted on both the first and second domain of the ALP molecule. These experiments showed that exposure of either intact ALP or its isolated first domain resulted in the elimination of the bacteria.
  • The second domain of the ALP molecule, on the other hand, showed little to no antibacterial activity.
  • These results suggest that the first domain of the ALP molecule might play an antimicrobial role, enhancing the body’s defence against infection.

Cite This Article

APA
Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. (1996). Antibacterial activity of antileukoprotease. Infect Immun, 64(11), 4520-4524. https://doi.org/10.1128/iai.64.11.4520-4524.1996

Publication

ISSN: 0019-9567
NlmUniqueID: 0246127
Country: United States
Language: English
Volume: 64
Issue: 11
Pages: 4520-4524

Researcher Affiliations

Hiemstra, P S
  • Department of Pulmonology, Leiden University Hospital, The Netherlands.
Maassen, R J
    Stolk, J
      Heinzel-Wieland, R
        Steffens, G J
          Dijkman, J H

            MeSH Terms

            • Anti-Bacterial Agents / chemistry
            • Anti-Bacterial Agents / pharmacology
            • Blood Proteins / pharmacology
            • Colony Count, Microbial
            • Defensins
            • Electrophoresis, Polyacrylamide Gel
            • Escherichia coli / drug effects
            • Escherichia coli / growth & development
            • Humans
            • Hydrogen-Ion Concentration
            • Microbial Sensitivity Tests
            • Muramidase / pharmacology
            • Pancreatic Elastase / antagonists & inhibitors
            • Proteinase Inhibitory Proteins, Secretory
            • Proteins / chemistry
            • Proteins / pharmacology
            • Recombinant Proteins / pharmacology
            • Serine Proteinase Inhibitors / pharmacology
            • Staphylococcus aureus / drug effects
            • Staphylococcus aureus / growth & development

            References

            This article includes 37 references
            1. Bju00f6rck L, Akesson P, Bohus M, Trojnar J, Abrahamson M, Olafsson I, Grubb A. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor.. Nature 1989 Jan 26;337(6205):385-6.
              pubmed: 2643059doi: 10.1038/337385a0google scholar: lookup
            2. Lehrer RI, Barton A, Ganz T. Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry.. J Immunol Methods 1988 Apr 6;108(1-2):153-8.
              pubmed: 3127470doi: 10.1016/0022-1759(88)90414-0google scholar: lookup
            3. Miller KW, Evans RJ, Eisenberg SP, Thompson RC. Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli.. J Bacteriol 1989 Apr;171(4):2166-72.
            4. Meckelein B, Nikiforov T, Clemen A, Appelhans H. The location of inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yields an active inhibitor of three different proteinases.. Protein Eng 1990 Jan;3(3):215-20.
              pubmed: 2158659doi: 10.1093/protein/3.3.215google scholar: lookup
            5. Kramps JA, van Twisk C, Appelhans H, Meckelein B, Nikiforov T, Dijkman JH. Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain.. Biochim Biophys Acta 1990 Apr 19;1038(2):178-85.
              pubmed: 2158823doi: 10.1016/0167-4838(90)90202-qgoogle scholar: lookup
            6. Kramps JA, Franken C, Dijkman JH. Quantity of anti-leucoprotease relative to alpha 1-proteinase inhibitor in peripheral airspaces of the human lung.. Clin Sci (Lond) 1988 Oct;75(4):351-3.
              pubmed: 2461824doi: 10.1042/cs0750351google scholar: lookup
            7. Eisenberg SP, Hale KK, Heimdal P, Thompson RC. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor.. J Biol Chem 1990 May 15;265(14):7976-81.
              pubmed: 2110563
            8. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.. J Clin Invest 1990 Jul;86(1):300-8.
              pubmed: 2164045doi: 10.1172/JCI114699google scholar: lookup
            9. Wiedow O, Schru00f6der JM, Gregory H, Young JA, Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence.. J Biol Chem 1990 Sep 5;265(25):14791-5.
              pubmed: 2394696
            10. Lehrer RI, Ganz T. Antimicrobial polypeptides of human neutrophils.. Blood 1990 Dec 1;76(11):2169-81.
              pubmed: 2257291
            11. McElvaney NG, Hubbard RC, Birrer P, Chernick MS, Caplan DB, Frank MM, Crystal RG. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.. Lancet 1991 Feb 16;337(8738):392-4.
              pubmed: 1671425doi: 10.1016/0140-6736(91)91167-sgoogle scholar: lookup
            12. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.. Biochim Biophys Acta 1991 Feb 22;1096(2):148-54.
              pubmed: 2001428doi: 10.1016/0925-4439(91)90053-cgoogle scholar: lookup
            13. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides.. J Immunol Methods 1991 Mar 21;137(2):167-73.
              pubmed: 1901580doi: 10.1016/0022-1759(91)90021-7google scholar: lookup
            14. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.. Proc Natl Acad Sci U S A 1991 May 1;88(9):3952-6.
              pubmed: 2023943doi: 10.1073/pnas.88.9.3952google scholar: lookup
            15. Kramps JA, Rudolphus A, Stolk J, Willems LN, Dijkman JH. Role of antileukoprotease in the human lung.. Ann N Y Acad Sci 1991;624:97-108.
            16. Van-Seuningen I, Davril M. Separation of the two domains of human mucus proteinase inhibitor: inhibitory activity is only located in the carboxy-terminal domain.. Biochem Biophys Res Commun 1991 Sep 30;179(3):1587-92.
              pubmed: 1930199doi: 10.1016/0006-291x(91)91755-2google scholar: lookup
            17. Rudolphus A, Heinzel-Wieland R, Vincent VA, Saunders D, Steffens GJ, Dijkman JH, Kramps JA. Oxidation-resistant variants of recombinant antileucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease.. Clin Sci (Lond) 1991 Dec;81(6):777-84.
              pubmed: 1662584doi: 10.1042/cs0810777google scholar: lookup
            18. Pellegrini A, Thomas U, von Fellenberg R, Wild P. Bactericidal activities of lysozyme and aprotinin against gram-negative and gram-positive bacteria related to their basic character.. J Appl Bacteriol 1992 Mar;72(3):180-7.
            19. McElvaney NG, Nakamura H, Birrer P, Hu00e9bert CA, Wong WL, Alphonso M, Baker JB, Catalano MA, Crystal RG. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.. J Clin Invest 1992 Oct;90(4):1296-301.
              pubmed: 1357002doi: 10.1172/JCI115994google scholar: lookup
            20. Couto MA, Harwig SS, Cullor JS, Hughes JP, Lehrer RI. eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.. Infect Immun 1992 Dec;60(12):5042-7.
            21. Couto MA, Harwig SS, Lehrer RI. Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils.. Infect Immun 1993 Jul;61(7):2991-4.
            22. Ying QL, Kemme M, Simon SR. Functions of the N-terminal domain of secretory leukoprotease inhibitor.. Biochemistry 1994 May 10;33(18):5445-50.
              pubmed: 7910033doi: 10.1021/bi00184a013google scholar: lookup
            23. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.. J Clin Invest 1995 Jul;96(1):456-64.
              pubmed: 7615818doi: 10.1172/JCI118056google scholar: lookup
            24. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates.. J Leukoc Biol 1995 Aug;58(2):128-36.
              pubmed: 7643008doi: 10.1002/jlb.58.2.128google scholar: lookup
            25. Schill WB, Schumacher GF. Radial diffusion in gel for micro determination of enzymes. I. Muramidase, alpha-amylase, DNase 1, RNase A, acid phosphatase, and alkaline phosphatase.. Anal Biochem 1972 Apr;46(2):502-33.
              pubmed: 4502712doi: 10.1016/0003-2697(72)90324-7google scholar: lookup
            26. Feinstein G, Janoff A. A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase.. Biochim Biophys Acta 1975 Oct 22;403(2):493-505.
              pubmed: 810168doi: 10.1016/0005-2744(75)90077-7google scholar: lookup
            27. Drenth J, Low BW, Richardson JS, Wright CS. The toxin-agglutinin fold. A new group of small protein structures organized around a four-disulfide core.. J Biol Chem 1980 Apr 10;255(7):2652-5.
              pubmed: 6892639
            28. Kramps JA, Franken C, Meijer CJ, Dijkman JH. Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract.. J Histochem Cytochem 1981 Jun;29(6):712-9.
              pubmed: 6788837doi: 10.1177/29.6.6788837google scholar: lookup
            29. Kramps JA, van der Valk P, van der Sandt MM, Lindeman J, Meijer CJ. Elastase as a marker for neutrophilic myeloid cells.. J Histochem Cytochem 1984 Apr;32(4):389-94.
              pubmed: 6561228doi: 10.1177/32.4.6561228google scholar: lookup
            30. Stockley RA. Measurement of soluble proteins in lung secretions.. Thorax 1984 Apr;39(4):241-7.
              pubmed: 6372152doi: 10.1136/thx.39.4.241google scholar: lookup
            31. Kramps JA, Franken C, Dijkman JH. ELISA for quantitative measurement of low-molecular-weight bronchial protease inhibitor in human sputum.. Am Rev Respir Dis 1984 Jun;129(6):959-63.
              pubmed: 6375492doi: 10.1164/arrd.1984.129.6.959google scholar: lookup
            32. Bieth JG. In vivo significance of kinetic constants of protein proteinase inhibitors.. Biochem Med 1984 Dec;32(3):387-97.
              pubmed: 6517881doi: 10.1016/0006-2944(84)90046-2google scholar: lookup
            33. Kramps JA, Klasen EC. Characterization of a low molecular weight anti-elastase isolated from human bronchial secretion.. Exp Lung Res 1985;9(1-2):151-65.
              pubmed: 3933966doi: 10.3109/01902148509061534google scholar: lookup
            34. Seemu00fcller U, Arnhold M, Fritz H, Wiedenmann K, Machleidt W, Heinzel R, Appelhans H, Gassen HG, Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor.. FEBS Lett 1986 Apr 7;199(1):43-8.
              pubmed: 3485543doi: 10.1016/0014-5793(86)81220-0google scholar: lookup
            35. Stockley RA. alpha-1-Antitrypsin and the pathogenesis of emphysema.. Lung 1987;165(2):61-77.
              pubmed: 3104702doi: 10.1007/BF02714424google scholar: lookup
            36. Schu00e4gger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.. Anal Biochem 1987 Nov 1;166(2):368-79.
              pubmed: 2449095doi: 10.1016/0003-2697(87)90587-2google scholar: lookup
            37. Franken C, Meijer CJ, Dijkman JH. Tissue distribution of antileukoprotease and lysozyme in humans.. J Histochem Cytochem 1989 Apr;37(4):493-8.
              pubmed: 2926127doi: 10.1177/37.4.2926127google scholar: lookup

            Citations

            This article has been cited 104 times.
            1. Myszor IT, Gudmundsson GH. Modulation of innate immunity in airway epithelium for host-directed therapy.. Front Immunol 2023;14:1197908.
              doi: 10.3389/fimmu.2023.1197908pubmed: 37251385google scholar: lookup
            2. van der Krieken DA, Rikken G, Ederveen THA, Jansen PAM, Rodijk-Olthuis D, Meesters LD, van Vlijmen-Willems IMJJ, van Cranenbroek B, van der Molen RG, Schalkwijk J, van den Bogaard EH, Zeeuwen PLJM. Gram-positive anaerobic cocci guard skin homeostasis by regulating host-defense mechanisms.. iScience 2023 Apr 21;26(4):106483.
              doi: 10.1016/j.isci.2023.106483pubmed: 37096035google scholar: lookup
            3. Baindara P, Ganguli S, Chakraborty R, Mandal SM. Preventing Respiratory Viral Diseases with Antimicrobial Peptide Master Regulators in the Lung Airway Habitat.. Clin Pract 2023 Jan 16;13(1):125-147.
              doi: 10.3390/clinpract13010012pubmed: 36648852google scholar: lookup
            4. Osbourn M, Rodgers AM, Dubois AV, Small DM, Humphries F, Delagic N, Moynagh PN, Weldon S, Taggart CC, Ingram RJ. Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute Pseudomonas aeruginosa Infection by Suppression of Inflammation Rather Than Microbial Killing.. Biomolecules 2022 Nov 22;12(12).
              doi: 10.3390/biom12121728pubmed: 36551159google scholar: lookup
            5. Nugteren S, Simons-Oosterhuis Y, Menckeberg CL, Hulleman-van Haaften DH, Lindenbergh-Kortleve DJ, Samsom JN. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.. Eur J Immunol 2023 Feb;53(2):e2249964.
              doi: 10.1002/eji.202249964pubmed: 36480463google scholar: lookup
            6. Barreto C, Matos GM, Rosa RD. On the wave of the crustin antimicrobial peptide family: From sequence diversity to function.. Fish Shellfish Immunol Rep 2022 Dec;3:100069.
              doi: 10.1016/j.fsirep.2022.100069pubmed: 36419607google scholar: lookup
            7. Ung L, Chodosh J. Foundational concepts in the biology of bacterial keratitis.. Exp Eye Res 2021 Aug;209:108647.
              doi: 10.1016/j.exer.2021.108647pubmed: 34097906google scholar: lookup
            8. Page LK, Staples KJ, Spalluto CM, Watson A, Wilkinson TMA. Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease.. Front Immunol 2021;12:653969.
              doi: 10.3389/fimmu.2021.653969pubmed: 33868294google scholar: lookup
            9. Laputkovu00e1 G, Schwartzovu00e1 V, Bu00e1novu010din J, Alexoviu010d M, Sabo J. Salivary Protein Roles in Oral Health and as Predictors of Caries Risk.. Open Life Sci 2018 Jan;13:174-200.
              doi: 10.1515/biol-2018-0023pubmed: 33817083google scholar: lookup
            10. Jaeger N, McDonough RT, Rosen AL, Hernandez-Leyva A, Wilson NG, Lint MA, Russler-Germain EV, Chai JN, Bacharier LB, Hsieh CS, Kau AL. Airway Microbiota-Host Interactions Regulate Secretory Leukocyte Protease Inhibitor Levels and Influence Allergic Airway Inflammation.. Cell Rep 2020 Nov 3;33(5):108331.
              doi: 10.1016/j.celrep.2020.108331pubmed: 33147448google scholar: lookup
            11. Nugteren S, Goos JACM, Delis-van Diemen PM, Simons-Oosterhuis Y, Lindenbergh-Kortleve DJ, van Haaften DH, Sanders J, Meijer GA, Fijneman RJA, Samsom JN. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.. Oncoimmunology 2020 Oct 13;9(1):1832761.
              doi: 10.1080/2162402X.2020.1832761pubmed: 33101778google scholar: lookup
            12. Ederveen THA, Smits JPH, Boekhorst J, Schalkwijk J, van den Bogaard EH, Zeeuwen PLJM. Skin microbiota in health and disease: From sequencing to biology.. J Dermatol 2020 Oct;47(10):1110-1118.
              doi: 10.1111/1346-8138.15536pubmed: 32804417google scholar: lookup
            13. Li S, Lv X, Yu Y, Zhang X, Li F. Molecular and Functional Diversity of Crustin-Like Genes in the Shrimp Litopenaeus vannamei.. Mar Drugs 2020 Jul 13;18(7).
              doi: 10.3390/md18070361pubmed: 32668696google scholar: lookup
            14. Manning R, James CP, Smith MC, Innes BA, Stamp E, Peebles D, Bajaj-Elliott M, Klein N, Bulmer JN, Robson SC, Lash GE. Predictive value of cervical cytokine, antimicrobial and microflora levels for pre-term birth in high-risk women.. Sci Rep 2019 Aug 2;9(1):11246.
              doi: 10.1038/s41598-019-47756-7pubmed: 31375740google scholar: lookup
            15. Molloy K, Smith SG, Cagney G, Dillon ET, Greene CM, McElvaney NG. Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases.. Pathogens 2019 Jun 28;8(3).
              doi: 10.3390/pathogens8030092pubmed: 31261656google scholar: lookup
            16. Lange A, Cajander S, Magnuson A, Sundu00e9n-Cullberg J, Stru00e5lin K, Hultgren O. Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection.. Eur J Clin Microbiol Infect Dis 2019 Aug;38(8):1425-1434.
              doi: 10.1007/s10096-019-03567-2pubmed: 31089838google scholar: lookup
            17. Vandooren J, Goeminne P, Boon L, Ugarte-Berzal E, Rybakin V, Proost P, Abu El-Asrar AM, Opdenakker G. Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.. Front Immunol 2018;9:1154.
              doi: 10.3389/fimmu.2018.01154pubmed: 29892293google scholar: lookup
            18. Valenti P, Rosa L, Capobianco D, Lepanto MS, Schiavi E, Cutone A, Paesano R, Mastromarino P. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.. Front Immunol 2018;9:376.
              doi: 10.3389/fimmu.2018.00376pubmed: 29545798google scholar: lookup
            19. Ordonez SR, Veldhuizen EJA, van Eijk M, Haagsman HP. Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens.. Front Microbiol 2017;8:2098.
              doi: 10.3389/fmicb.2017.02098pubmed: 29163395google scholar: lookup
            20. Leiva-Juu00e1rez MM, Kolls JK, Evans SE. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.. Mucosal Immunol 2018 Jan;11(1):21-34.
              doi: 10.1038/mi.2017.71pubmed: 28812547google scholar: lookup
            21. Ochi A, Chen D, Schulte W, Leng L, Moeckel N, Piecychna M, Averdunk L, Stoppe C, Bucala R, Moeckel G. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.. Am J Physiol Renal Physiol 2017 Sep 1;313(3):F767-F780.
              doi: 10.1152/ajprenal.00683.2016pubmed: 28539339google scholar: lookup
            22. De Santis S, Kunde D, Serino G, Galleggiante V, Caruso ML, Mastronardi M, Cavalcanti E, Ranson N, Pinto A, Campiglia P, Santino A, Eri R, Chieppa M. Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFu03b1 secretion.. Oncotarget 2016 Nov 15;7(46):75800-75809.
              doi: 10.18632/oncotarget.12415pubmed: 27716626google scholar: lookup
            23. Nicol AF, Brunette LL, Nuovo GJ, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Coutinho JR, Vianna-Andrade C, Oliveira NS, Woodham AW, DA Silva DM, Kast WM. Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.. J Acquir Immune Defic Syndr 2016 Sep 1;73(1):27-33.
              doi: 10.1097/QAI.0000000000001049pubmed: 27149102google scholar: lookup
            24. Camper N, Glasgow AM, Osbourn M, Quinn DJ, Small DM, McLean DT, Lundy FT, Elborn JS, McNally P, Ingram RJ, Weldon S, Taggart CC. A secretory leukocyte protease inhibitor variant with improved activity against lung infection.. Mucosal Immunol 2016 May;9(3):669-76.
              doi: 10.1038/mi.2015.90pubmed: 26376365google scholar: lookup
            25. McGarry N, Greene CM, McElvaney NG, Weldon S, Taggart CC. The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity.. J Immunol Res 2015;2015:507315.
              doi: 10.1155/2015/507315pubmed: 26247039google scholar: lookup
            26. Twigg MS, Brockbank S, Lowry P, FitzGerald SP, Taggart C, Weldon S. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.. Mediators Inflamm 2015;2015:293053.
              doi: 10.1155/2015/293053pubmed: 26185359google scholar: lookup
            27. Pellett Madan R, Dezzutti CS, Rabe L, Hillier SL, Marrazzo J, McGowan I, Richardson BA, Herold BC. Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.. Am J Reprod Immunol 2015 Oct;74(4):323-32.
              doi: 10.1111/aji.12412pubmed: 26118476google scholar: lookup
            28. Aslanidis A, Karlstetter M, Scholz R, Fauser S, Neumann H, Fried C, Pietsch M, Langmann T. Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFu03baB signaling and induces a neuroprotective phenotype in microglia.. J Neuroinflammation 2015 Apr 19;12:77.
              doi: 10.1186/s12974-015-0296-6pubmed: 25928566google scholar: lookup
            29. Zabieglo K, Majewski P, Majchrzak-Gorecka M, Wlodarczyk A, Grygier B, Zegar A, Kapinska-Mrowiecka M, Naskalska A, Pyrc K, Dubin A, Wahl SM, Cichy J. The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.. J Leukoc Biol 2015 Jul;98(1):99-106.
              doi: 10.1189/jlb.4AB1114-543Rpubmed: 25917460google scholar: lookup
            30. Meyer M, Jaspers I. Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants.. Am J Physiol Lung Cell Mol Physiol 2015 Jun 15;308(12):L1189-201.
              doi: 10.1152/ajplung.00028.2015pubmed: 25888573google scholar: lookup
            31. Pu00e5hlman LI, Ju00f6gi A, Gram M, Mori M, Egesten A. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-u03b21.. BMC Pulm Med 2015 Mar 7;15:19.
              doi: 10.1186/s12890-015-0016-0pubmed: 25851169google scholar: lookup
            32. Dervishi E, Lam TH, Dunn SM, Zwierzchowski G, Saleem F, Wishart DS, Ametaj BN. Recombinant mouse prion protein alone or in combination with lipopolysaccharide alters expression of innate immunity genes in the colon of mice.. Prion 2015;9(1):59-73.
              doi: 10.1080/19336896.2015.1019694pubmed: 25695140google scholar: lookup
            33. McCartney-Francis N, Jin W, Belkaid Y, McGrady G, Wahl SM. Aberrant host defense against Leishmania major in the absence of SLPI.. J Leukoc Biol 2014 Nov;96(5):917-29.
              doi: 10.1189/jlb.4A0612-295RRpubmed: 25030421google scholar: lookup
            34. Li S, Jin XK, Guo XN, Yu AQ, Wu MH, Tan SJ, Zhu YT, Li WW, Wang Q. A double WAP domain-containing protein Es-DWD1 from Eriocheir sinensis exhibits antimicrobial and proteinase inhibitory activities.. PLoS One 2013;8(8):e73563.
              doi: 10.1371/journal.pone.0073563pubmed: 23967346google scholar: lookup
            35. Nordin SL, Andersson C, Bjermer L, Bjartell A, Mu00f6rgelin M, Egesten A. Midkine is part of the antibacterial activity released at the surface of differentiated bronchial epithelial cells.. J Innate Immun 2013;5(5):519-30.
              doi: 10.1159/000346709pubmed: 23391998google scholar: lookup
            36. Johannessen M, Sollid JE, Hanssen AM. Host- and microbe determinants that may influence the success of S. aureus colonization.. Front Cell Infect Microbiol 2012;2:56.
              doi: 10.3389/fcimb.2012.00056pubmed: 22919647google scholar: lookup
            37. Eliasson M, Olin AI, Malmstru00f6m JA, Mu00f6rgelin M, Bodelsson M, Collin M, Egesten A. Characterization of released polypeptides during an interferon-u03b3-dependent antibacterial response in airway epithelial cells.. J Interferon Cytokine Res 2012 Nov;32(11):524-33.
              doi: 10.1089/jir.2012.0017pubmed: 22909116google scholar: lookup
            38. Jefferson WN, Padilla-Banks E, Phelps JY, Cantor AM, Williams CJ. Neonatal phytoestrogen exposure alters oviduct mucosal immune response to pregnancy and affects preimplantation embryo development in the mouse.. Biol Reprod 2012 Jul;87(1):10, 1-10.
              doi: 10.1095/biolreprod.112.099846pubmed: 22553218google scholar: lookup
            39. Cooper MD, Roberts MH, Barauskas OL, Jarvis GA. Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.. Am J Reprod Immunol 2012 Aug;68(2):116-27.
            40. Rajesh A, Yenugu S. Genomic organization, tissue distribution and functional characterization of the rat Pate gene cluster.. PLoS One 2012;7(3):e32633.
              doi: 10.1371/journal.pone.0032633pubmed: 22479333google scholar: lookup
            41. Mu00fcller AM, Jun E, Conlon H, Sadiq SA. Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.. BMC Neurosci 2012 Mar 21;13:30.
              doi: 10.1186/1471-2202-13-30pubmed: 22436018google scholar: lookup
            42. Laugisch O, Schacht M, Guentsch A, Kantyka T, Sroka A, Stennicke HR, Pfister W, Sculean A, Potempa J, Eick S. Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid.. Mol Oral Microbiol 2012 Feb;27(1):45-56.
            43. Narmadha G, Muneswararao K, Rajesh A, Yenugu S. Characterization of a novel lysozyme-like 4 gene in the rat.. PLoS One 2011;6(11):e27659.
              doi: 10.1371/journal.pone.0027659pubmed: 22110709google scholar: lookup
            44. Wex T, Kuester D, Schu00f6nberg C, Schindele D, Treiber G, Malfertheiner P. Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression.. BMC Gastroenterol 2011 May 26;11:63.
              doi: 10.1186/1471-230X-11-63pubmed: 21612671google scholar: lookup
            45. Guerrieri D, Tateosian NL, Maffu00eda PC, Reiteri RM, Amiano NO, Costa MJ, Villalonga X, Sanchez ML, Estein SM, Garcia VE, Sallenave JM, Chuluyan HE. Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation.. Immunology 2011 Aug;133(4):434-41.
            46. Zuyderduyn S, Ninaber DK, Schrumpf JA, van Sterkenburg MA, Verhoosel RM, Prins FA, van Wetering S, Rabe KF, Hiemstra PS. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides.. Respir Res 2011 May 2;12(1):59.
              doi: 10.1186/1465-9921-12-59pubmed: 21529380google scholar: lookup
            47. Schwaab M, Gurr A, Neumann A, Dazert S, Minovi A. Human antimicrobial proteins in ear wax.. Eur J Clin Microbiol Infect Dis 2011 Aug;30(8):997-1004.
              doi: 10.1007/s10096-011-1185-2pubmed: 21298458google scholar: lookup
            48. Coutinho HD, Lu00f4bo KM, Bezerra DA, Lu00f4bo I. Peptides and proteins with antimicrobial activity.. Indian J Pharmacol 2008 Jan;40(1):3-9.
              doi: 10.4103/0253-7613.40481pubmed: 21264153google scholar: lookup
            49. Ali M, Lillehoj EP, Park Y, Kyo Y, Kim KC. Analysis of the proteome of human airway epithelial secretions.. Proteome Sci 2011 Jan 20;9:4.
              doi: 10.1186/1477-5956-9-4pubmed: 21251289google scholar: lookup
            50. Wira CR, Ghosh M, Smith JM, Shen L, Connor RI, Sundstrom P, Frechette GM, Hill ET, Fahey JV. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus.. Mucosal Immunol 2011 May;4(3):335-42.
              doi: 10.1038/mi.2010.72pubmed: 21048705google scholar: lookup
            51. Liu G, Saxena D, Deng H, Norman RG, Chen Z, Abrams WR, Malamud D, Li Y. Effect of protease inhibitors on the quantitative and qualitative assessment of oral microorganisms.. FEMS Microbiol Lett 2010 Nov;312(1):63-70.
            52. McCormick TS, Weinberg A. Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity.. Periodontol 2000 2010 Oct;54(1):195-206.
            53. Reviglio VE, Grenat A, Pegoraro F, Sambuelli RH, Rana T, Kuo IC. Secretory Leukoprotease Inhibitor: A Native Antimicrobial Protein in the Innate Immune Response in a Rat Model of S. aureus Keratitis.. J Ophthalmol 2009;2009:259393.
              doi: 10.1155/2009/259393pubmed: 20309414google scholar: lookup
            54. Weldon S, McNally P, McElvaney NG, Elborn JS, McAuley DF, Wartelle J, Belaaouaj A, Levine RL, Taggart CC. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.. J Immunol 2009 Dec 15;183(12):8148-56.
              doi: 10.4049/jimmunol.0901716pubmed: 20007580google scholar: lookup
            55. Greene CM, McElvaney NG. Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.. Br J Pharmacol 2009 Oct;158(4):1048-58.
            56. Li Q, Zhou XD, Xu XY, Yang J. Recombinant human elafin protects airway epithelium integrity during inflammation.. Mol Biol Rep 2010 Jul;37(6):2981-8.
              doi: 10.1007/s11033-009-9865-zpubmed: 19823954google scholar: lookup
            57. Li Z, Moy A, Sohal K, Dam C, Kuo P, Whittaker J, Whittaker M, Du00fczgu00fcnes N, Konopka K, Franz AH, Lin-Cereghino J, Lin-Cereghino GP. Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris.. Protein Expr Purif 2009 Oct;67(2):175-81.
              doi: 10.1016/j.pep.2009.06.001pubmed: 19505578google scholar: lookup
            58. Dutta K, Nandi D, Bishayi B. Repeated systemic Escherichia coli infection enhances anti-oxidant response in hypercholesterolemic mice inducing cardiovascular inflammation.. Inflammation 2009 Apr;32(2):89-98.
              doi: 10.1007/s10753-009-9107-5pubmed: 19221870google scholar: lookup
            59. van den Bogaard EH, Dailey LA, Thorley AJ, Tetley TD, Forbes B. Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1).. Pharm Res 2009 May;26(5):1172-80.
              doi: 10.1007/s11095-009-9838-xpubmed: 19199008google scholar: lookup
            60. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, Rossoll RM, Wira CR. Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture.. Mucosal Immunol 2008 Jul;1(4):317-25.
              doi: 10.1038/mi.2008.20pubmed: 19079193google scholar: lookup
            61. Sullivan AL, Dafforn T, Hiemstra PS, Stockley RA. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.. Respir Res 2008 Aug 12;9(1):60.
              doi: 10.1186/1465-9921-9-60pubmed: 18699987google scholar: lookup
            62. Fakioglu E, Wilson SS, Mesquita PM, Hazrati E, Cheshenko N, Blaho JA, Herold BC. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.. J Virol 2008 Oct;82(19):9337-44.
              doi: 10.1128/JVI.00603-08pubmed: 18667508google scholar: lookup
            63. Mueller AM, Pedru00e9 X, Stempfl T, Kleiter I, Couillard-Despres S, Aigner L, Giegerich G, Steinbrecher A. Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis.. J Neuroinflammation 2008 May 26;5:20.
              doi: 10.1186/1742-2094-5-20pubmed: 18501024google scholar: lookup
            64. Imjongjirak C, Amparyup P, Tassanakajon A, Sittipraneed S. Molecular cloning and characterization of crustin from mud crab Scylla paramamosain.. Mol Biol Rep 2009 May;36(5):841-50.
              doi: 10.1007/s11033-008-9253-0pubmed: 18425600google scholar: lookup
            65. Reviglio VE, Sambuelli RH, Olmedo A, Falco M, Echenique J, O'Brien TP, Kuo IC. Secretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitis.. Mediators Inflamm 2007;2007:93857.
              doi: 10.1155/2007/93857pubmed: 18274645google scholar: lookup
            66. Yamasaki K, Gallo RL. Antimicrobial peptides in human skin disease.. Eur J Dermatol 2008 Jan-Feb;18(1):11-21.
              doi: 10.1684/ejd.2008.0304pubmed: 18086583google scholar: lookup
            67. Bellemare A, Vernoux N, Morisset D, Bourbonnais Y. Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.. Antimicrob Agents Chemother 2008 Feb;52(2):483-90.
              doi: 10.1128/AAC.00585-07pubmed: 18025118google scholar: lookup
            68. Propst-Graham KL, Preheim LC, Vander Top EA, Snitily MU, Gentry-Nielsen MJ. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.. BMC Microbiol 2007 Oct 23;7:94.
              doi: 10.1186/1471-2180-7-94pubmed: 17956621google scholar: lookup
            69. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis.. Infect Immun 2006 Oct;74(10):5693-702.
              doi: 10.1128/IAI.00524-06pubmed: 16988245google scholar: lookup
            70. Lee JK, Chae SW, Cho JG, Lee HM, Hwang SJ, Jung HH. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.. Eur Arch Otorhinolaryngol 2006 Dec;263(12):1077-81.
              doi: 10.1007/s00405-006-0126-7pubmed: 16868773google scholar: lookup
            71. Chowdhury MA, Kuivaniemi H, Romero R, Edwin S, Chaiworapongsa T, Tromp G. Identification of novel functional sequence variants in the gene for peptidase inhibitor 3.. BMC Med Genet 2006 May 23;7:49.
              doi: 10.1186/1471-2350-7-49pubmed: 16719916google scholar: lookup
            72. Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA, Bingle CD. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.. Respir Res 2006 Apr 6;7(1):61.
              doi: 10.1186/1465-9921-7-61pubmed: 16600032google scholar: lookup
            73. Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG. Antimicrobial proteins and polypeptides in pulmonary innate defence.. Respir Res 2006 Feb 17;7(1):29.
              doi: 10.1186/1465-9921-7-29pubmed: 16503962google scholar: lookup
            74. Ding A, Yu H, Yang J, Shi S, Ehrt S. Induction of macrophage-derived SLPI by Mycobacterium tuberculosis depends on TLR2 but not MyD88.. Immunology 2005 Nov;116(3):381-9.
            75. Brown TI, Mistry R, Gray R, Imrie M, Collie DD, Sallenave JM. Characterization of the ovine ortholog of secretory leukoprotease inhibitor.. Mamm Genome 2005 Aug;16(8):621-30.
              doi: 10.1007/s00335-005-0030-2pubmed: 16180144google scholar: lookup
            76. Clauss A, Lilja H, Lundwall A. The evolution of a genetic locus encoding small serine proteinase inhibitors.. Biochem Biophys Res Commun 2005 Jul 29;333(2):383-9.
              doi: 10.1016/j.bbrc.2005.05.125pubmed: 15950183google scholar: lookup
            77. Jana NK, Gray LR, Shugars DC. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.. J Virol 2005 May;79(10):6432-40.
            78. Doumas S, Kolokotronis A, Stefanopoulos P. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.. Infect Immun 2005 Mar;73(3):1271-4.
            79. Greene CM, McElvaney NG, O'Neill SJ, Taggart CC. Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells.. Infect Immun 2004 Jun;72(6):3684-7.
            80. Wex T, Treiber G, Nilius M, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum.. Infect Immun 2004 Apr;72(4):2383-5.
            81. Chattopadhyay A, Gray LR, Patton LL, Caplan DJ, Slade GD, Tien HC, Shugars DC. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.. Infect Immun 2004 Apr;72(4):1956-63.
            82. Wira CR, Fahey JV. The innate immune system: gatekeeper to the female reproductive tract.. Immunology 2004 Jan;111(1):13-5.
            83. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium.. Reprod Biol Endocrinol 2003 Nov 28;1:116.
              doi: 10.1186/1477-7827-1-116pubmed: 14641912google scholar: lookup
            84. White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, Stockley RA. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.. Thorax 2003 Aug;58(8):680-5.
              doi: 10.1136/thorax.58.8.680pubmed: 12885984google scholar: lookup
            85. Sallenave JM, Cunningham GA, James RM, McLachlan G, Haslett C. Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin.. Infect Immun 2003 Jul;71(7):3766-74.
            86. Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, Brys L, De Baetselier P, Revets H. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.. Proc Natl Acad Sci U S A 2003 May 13;100(10):5778-82.
              doi: 10.1073/pnas.1037154100pubmed: 12732717google scholar: lookup
            87. Yenugu S, Hamil KG, Birse CE, Ruben SM, French FS, Hall SH. Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli.. Biochem J 2003 Jun 1;372(Pt 2):473-83.
              doi: 10.1042/BJ20030225pubmed: 12628001google scholar: lookup
            88. Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.. J Exp Med 2003 Mar 3;197(5):669-74.
              doi: 10.1084/jem.20021824pubmed: 12615907google scholar: lookup
            89. Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.. Clin Exp Immunol 2003 Jan;131(1):190-6.
            90. Clauss A, Lilja H, Lundwall A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein.. Biochem J 2002 Nov 15;368(Pt 1):233-42.
              doi: 10.1042/BJ20020869pubmed: 12206714google scholar: lookup
            91. Fernie-King BA, Seilly DJ, Davies A, Lachmann PJ. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.. Infect Immun 2002 Sep;70(9):4908-16.
            92. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract.. J Clin Invest 2002 Mar;109(6):693-7.
              doi: 10.1172/JCI15218pubmed: 11901174google scholar: lookup
            93. Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.. Mediators Inflamm 2001 Dec;10(6):347-50.
              doi: 10.1080/09629350120102389pubmed: 11817677google scholar: lookup
            94. Nystru00f6m M, Westin UP, Linder C, Ohlsson K. Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.. Mediators Inflamm 2001 Oct;10(5):269-72.
              doi: 10.1080/09629350120093740pubmed: 11759111google scholar: lookup
            95. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW 3rd, Mestecky J. Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.. Infect Immun 2001 Nov;69(11):7178-81.
            96. Nystru00f6m M, Bergenfeldt M, Ljungcrantz I, Lindeheim A, Ohlsson K. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.. Mediators Inflamm 1999;8(3):147-51.
              doi: 10.1080/09629359990478pubmed: 10704052google scholar: lookup
            97. Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray PB Jr. Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins.. Infect Immun 1999 Sep;67(9):4827-33.
            98. Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.. Infect Immun 1999 Sep;67(9):4485-9.
            99. Song Xy, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, Billinghurst RC, Poole AR, Wahl SM. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis.. J Exp Med 1999 Aug 16;190(4):535-42.
              doi: 10.1084/jem.190.4.535pubmed: 10449524google scholar: lookup
            100. Brogden KA, Ackermann MR, McCray PB Jr, Huttner KM. Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis.. Infect Immun 1999 Aug;67(8):4256-9.
            101. Tomee JF, Kou00ebter GH, Hiemstra PS, Kauffman HF. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?. Thorax 1998 Feb;53(2):114-6.
              doi: 10.1136/thx.53.2.114pubmed: 9624296google scholar: lookup
            102. Jin F, Nathan CF, Radzioch D, Ding A. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.. Infect Immun 1998 Jun;66(6):2447-52.
            103. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.. J Clin Invest 1998 Apr 15;101(8):1633-42.
              doi: 10.1172/JCI1861pubmed: 9541493google scholar: lookup
            104. Kammouni W, Figarella C, Marchand S, Merten M. Altered cytokine production by cystic fibrosis tracheal gland serous cells.. Infect Immun 1997 Dec;65(12):5176-83.